Sumitomo Mitsui Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

  • $145 Billion
  • Q4 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 302,616 shares of REGN stock, worth $217 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
302,616
Previous 301,508 0.37%
Holding current value
$217 Million
Previous $317 Million 31.99%
% of portfolio
0.15%
Previous 0.22%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
BUY
$701.85 - $1046.91 $777,649 - $1.16 Million
1,108 Added 0.37%
302,616 $216 Million
Q3 2024

Nov 05, 2024
BUY
$1024.09 - $1201.76 $3.96 Million - $4.65 Million
3,866 Added 1.3%
301,508 $317 Million
Q2 2024

Jul 19, 2024
SELL
$883.2 - $1071.19 $18.9 Million - $22.9 Million
-21,406 Reduced 6.71%
297,642 $313 Million
Q1 2024

Apr 19, 2024
SELL
$902.69 - $993.35 $271,709 - $298,998
-301 Reduced 0.09%
319,048 $307 Million
Q4 2023

Jan 30, 2024
SELL
$775.18 - $881.7 $6.95 Million - $7.91 Million
-8,972 Reduced 2.73%
319,349 $280 Million
Q3 2023

Oct 30, 2023
SELL
$692.45 - $844.37 $3.52 Million - $4.29 Million
-5,080 Reduced 1.52%
328,321 $270 Million
Q2 2023

Jul 31, 2023
SELL
$700.03 - $830.35 $27.8 Million - $33 Million
-39,737 Reduced 10.65%
333,401 $240 Million
Q1 2023

Apr 27, 2023
SELL
$680.49 - $826.97 $4.4 Million - $5.35 Million
-6,471 Reduced 1.7%
373,138 $307 Million
Q4 2022

Jan 30, 2023
SELL
$705.89 - $766.39 $8.15 Million - $8.84 Million
-11,541 Reduced 2.95%
379,609 $274 Million
Q3 2022

Oct 21, 2022
SELL
$573.97 - $724.32 $4.7 Million - $5.93 Million
-8,184 Reduced 2.05%
391,150 $269 Million
Q2 2022

Jul 26, 2022
SELL
$548.35 - $738.84 $4.02 Million - $5.42 Million
-7,340 Reduced 1.8%
399,334 $236 Million
Q1 2022

Apr 27, 2022
SELL
$595.12 - $698.43 $15.2 Million - $17.8 Million
-25,541 Reduced 5.91%
406,674 $284 Million
Q4 2021

Feb 02, 2022
SELL
$543.48 - $670.97 $20.1 Million - $24.9 Million
-37,054 Reduced 7.9%
432,215 $273 Million
Q3 2021

Oct 25, 2021
SELL
$574.03 - $680.96 $47.1 Million - $55.9 Million
-82,083 Reduced 14.89%
469,269 $284 Million
Q2 2021

Aug 02, 2021
BUY
$472.8 - $558.54 $26.2 Million - $31 Million
55,497 Added 11.19%
551,352 $308 Million
Q1 2021

Apr 30, 2021
BUY
$446.73 - $548.2 $20.7 Million - $25.4 Million
46,254 Added 10.29%
495,855 $235 Million
Q4 2020

Feb 05, 2021
SELL
$478.3 - $607.98 $5.25 Million - $6.67 Million
-10,971 Reduced 2.38%
449,601 $217 Million
Q3 2020

Oct 30, 2020
SELL
$544.75 - $658.21 $11.7 Million - $14.1 Million
-21,435 Reduced 4.45%
460,572 $258 Million
Q2 2020

Jul 27, 2020
BUY
$493.32 - $643.92 $39.9 Million - $52.1 Million
80,867 Added 20.16%
482,007 $301 Million
Q1 2020

Apr 27, 2020
SELL
$336.18 - $494.43 $21.7 Million - $32 Million
-64,683 Reduced 13.89%
401,140 $196 Million
Q4 2019

Jan 31, 2020
SELL
$274.13 - $376.51 $2.38 Million - $3.27 Million
-8,682 Reduced 1.83%
465,823 $175 Million
Q3 2019

Oct 31, 2019
BUY
$273.46 - $318.39 $10.1 Million - $11.7 Million
36,796 Added 8.41%
474,505 $132 Million
Q2 2019

Jul 29, 2019
BUY
$299.6 - $414.82 $33 Million - $45.7 Million
110,242 Added 33.67%
437,709 $137 Million
Q1 2019

May 08, 2019
BUY
$372.08 - $439.57 $8.47 Million - $10 Million
22,752 Added 7.47%
327,467 $134 Million
Q4 2018

Feb 06, 2019
BUY
$335.82 - $403.04 $17.3 Million - $20.8 Million
51,513 Added 20.34%
304,715 $110 Million
Q3 2018

Nov 07, 2018
BUY
$351.14 - $408.51 $2.12 Million - $2.47 Million
6,047 Added 2.45%
253,202 $102 Million
Q2 2018

Aug 01, 2018
BUY
$284.6 - $344.99 $6.71 Million - $8.13 Million
23,567 Added 10.54%
247,155 $85.3 Million
Q1 2018

May 01, 2018
BUY
$315.82 - $393.78 $1.2 Million - $1.5 Million
3,812 Added 1.73%
223,588 $77 Million
Q4 2017

Feb 06, 2018
BUY
$358.63 - $469.95 $1.03 Million - $1.35 Million
2,867 Added 1.32%
219,776 $82.6 Million
Q3 2017

Nov 07, 2017
SELL
$431.38 - $504.0 $1.35 Million - $1.58 Million
-3,131 Reduced 1.42%
216,909 $97 Million
Q2 2017

Aug 07, 2017
BUY
N/A
220,040
220,040 $108 Million

Others Institutions Holding REGN

# of Institutions
1,493
Shares Held
83.2M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email